In addition, the pre-S2 mutant-positive HCC patients have been shown to display increased expression of intra-tumoral PD-L1 and elevated number of tumor-infiltrating Tregs compared with pre-S2 mutant-negative HCC patients [66,67]. The gene discussed is CD274; the disease is hepatocellular carcinoma.